Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Antithrombotic Treatment After IntraCerebral Haemorrhage

NCT03186729 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT03186729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03186729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Antithrombotic Treatment After IntraCerebral Haemorrhage
Lead sponsor
Oslo University Hospital
Phase
Phase 4
Overall status
Terminated
Start date
July 1, 2018
Completion date
August 31, 2024
Enrollment
134 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant-induced bleeding, atrial fibrillation, cerebral hemorrhage, intracranial hemorrhages, secondary prevention